Organization
Kantonsspital St. Gallen, St. Gallen, Switzerland
2 abstracts
Abstract
BEAT-meso: A randomized phase III study of bevacizumab (B) and standard chemotherapy (C) with or without atezolizumab (A), as first-line treatment (TX) for advanced pleural mesothelioma (PM)—Results from the ETOP 13-18 trial.Org: Royal Marsden Hospital NHS Foundation Trust, Medical Oncology Service, Vall d’Hebron University Hospital/VHIO, Vall d’Hebron Institute of Oncology (VHIO), National and Kapodistrian University of Athens,
Abstract
“EVOLVING THE MANAGEMENT OF RA” PROGRAMME: EDUCATIONAL TOOLS TO SUPPORT DAILY PRACTICEOrg: LUMC, Leiden, Netherlands, Kantonsspital St. Gallen, St. Gallen, Switzerland, Medizinische Universität Wien, Vienna, Austria, University of Debrecen, Debrecen, Hungary, University of Oxford, Oxford, United Kingdom,